MedTrace Logo

Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol

NCT03067324 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-10-26

No results posted yet for this study

Summary

Islet quality control after pancreatic islets isolation process is insufficient. The Islet Chip study proposes to develop a bio-sensor that will allow a multi-parametric analysis of islet graft based on measurement of islet membrane electric potential.

Conditions

  • Pancreatic Islet Quality Control

Sponsors & Collaborators

  • University Hospital, Bordeaux

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Sandrine LABLANCHE, MD, PhD · University Hospital, Grenoble

  • Bogdan CATARGI, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-11
Primary Completion
2020-12-31
Completion
2021-07-01

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067324 on ClinicalTrials.gov